Fasting Blood Sugar (FBS / FPG)

Clinical interpretation, ADA diagnostic thresholds, prediabetes identification, and diabetic crisis evaluation for Fasting Plasma Glucose (FPG / FBS).

Editorial review complete

Independent clinical validation is pending.

Validation pending

Quick Reference Facts

Specimen TypeVenous Blood (Serum)
PreparationFasting optional unless ordered with lipid panel
Turnaround Time24–48 Hours
Clinical CategoryGeneral

Laboratory Interpretation Workflow

Stage 1 of 5

1. Clinical Indication

Ordering protocols based on clinical indications, presenting symptoms, or screening guidelines.

Clinical Pearl: Order when screening for primary organ dysfunctions or monitoring active treatment efficacy.

Test Description & Overview

Fasting Blood Sugar (Fasting Plasma Glucose / FPG): Quantitative measurement of blood venous plasma glucose concentration following a minimum 8-hour overnight caloric fast, serving as a primary diagnostic tool for diabetes mellitus and impaired fasting glucose.

Standard Reference Range

Normal: 70–99 mg/dL (3.9–5.5 mmol/L); Impaired Fasting Glucose (Prediabetes): 100–125 mg/dL (5.6–6.9 mmol/L); Diabetes Mellitus Diagnostic Threshold: ≥126 mg/dL (≥7.0 mmol/L) confirmed on repeat testing.

Elevated (High) Values

  • Type 1 and Type 2 Diabetes Mellitus, Gestational Diabetes Mellitus
  • Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS - glucose >600 mg/dL)
  • Cushing's Syndrome, Acromegaly, Acute Pancreatitis, Stress Hyperglycemia (Sepsis, Trauma, Steroid Therapy)

Decreased (Low) Values

  • Level 1 Hypoglycemia (54-70 mg/dL), Level 2 Severe Hypoglycemia (<54 mg/dL)
  • Exogenous Insulin or Sulfonylurea Overdose, Insulinoma, Severe Hepatic Failure, Adrenal Insufficiency

Clinical Alignment & Significance

Fasting glucose ≥126 mg/dL on two separate occasions confirms Diabetes Mellitus; extreme hyperglycemia (>300 mg/dL) with Kussmaul breathing or altered mental status demands emergency DKA/HHS management.

Diagnostic Guidance Notice

Standard laboratory reference ranges vary based on the testing facility. Significant deviations require immediate clinician review to rule out severe medical pathology.

Reference Citations & Evidence Sources

Clinical Guidelines & Consensus Statements
  • CIT-0070American Diabetes Association Professional Practice Committee. "Standards of Care in Diabetes—2024." Diabetes Care (2024).DOI PubMed
Clinical Reviews & Textbooks
  • CIT-0023National Center for Complementary and Integrative Health. "Homeopathy: What You Need To Know." National Institutes of Health (2021).

AI & Generative Search Citation Block

Entity IDL0015
Entity Typelab-test
Content Versionv1.1.0
Last Reviewed DateJul 31, 2026
Evidence LevelTraditional-Literature
Suggested Academic/LLM Citation format (AMA Style)

Dr. Narayan Jethwani. "Fasting Blood Sugar (FBS / FPG)." Homeo Healthcare Clinical Platform. Version 1.1.0. Reviewed: 2026-07-31T20:30:00Z. Available at: https://homeo.healthcare/knowledge/lab-tests/fasting-blood-sugar

Medical Safety Disclaimer

All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.